Amiad 2025: Irrigation Recovered, But Industry Tore A Hole In Profitability

Getting To Know The Company

Amiad is not a generic “water” story. It is an industrial company selling filtration and water-treatment solutions into two very different economic worlds. One is irrigation, where the business is closer to product distribution through dealers and OEMs. The other is industry, where revenue is tied more directly to projects, engineering customization, EPC partners, and infrastructure budgets that can be postponed when uncertainty rises. That split is the right way to read 2025.

What is actually working now? Irrigation came back, revenue in that segment rose to $56.5 million, and much of the recovery came from Europe and from Netafim returning to 2023 purchasing levels. What is still not working? Industry, which is still the larger revenue engine, fell to $63.7 million of sales and only $3.8 million of direct operating profit. Anyone focusing only on $5.3 million of operating cash flow or on lower net finance expense could think the turnaround is already in place. That is too generous a reading. The operating core weakened.

The active bottleneck is not immediate liquidity in the classic sense. Amiad still has bank lines, it is not facing financial covenants, and the banks are not forcing a near-term balance-sheet event. The real bottleneck is earnings quality in 2026. If the industrial segment enters the year with a weaker backlog while irrigation improvement leans materially on one anchor customer, the company still has to prove that automation, efficiency work, and its premium-market push can turn 2025 into a dip rather than into a new baseline.

The company operates in more than 90 countries, has companies and offices in 13 countries, and its key production sites are in Kibbutz Amiad, Kibbutz Beit Zera, and Turkey. The two segments are close in revenue size, but not in economic quality in the current year: industry generated 53% of 2025 revenue, while irrigation delivered 58% of direct segment profit. That gap should shape the whole reading of the year.

This also explains what a superficial reader is likely to misread. If you only look at irrigation growth, better operating cash flow, and the absence of any meaningful short pressure in the stock, the report can look like an early-stage recovery. But when backlog, segment profitability, and cash usage are read together, the picture is a company still searching for a cleaner center of gravity. 2025 does not read like a breakout year. It reads like a partial stabilization year ahead of a harder test.

Events And Triggers

The first trigger: Amiad entered 2026 with a lower backlog. Irrigation backlog was slightly higher at $8.1 million versus $8.0 million, but industrial backlog fell to $24.8 million from $35.1 million. That is not a cosmetic line. It means the segment that should carry large projects and a meaningful share of profit is starting the year from a visibly weaker work base.

The second trigger: The distribution agreement with Netafim, the company’s main irrigation customer, runs through the end of 2026 and the two sides are already discussing an extension. That matters because Customer A generated $14.0 million in 2025, or 11.6% of group revenue, after falling to 8.1% in 2024. In plain terms, part of the irrigation recovery is already sitting on one customer whose weight has risen again.

The third trigger: Management keeps framing 2026 around sales growth, operating efficiency, automation, and continued M&A screening. That is directionally fine, but the near-term trigger is not a future acquisition. It is whether industrial orders and gross profit can recover from here. Without that, acquisition talk sits on a soft base.

The fourth trigger: The company received approval for a fixed-asset investment program of roughly NIS 34 million, with a maximum grant of 20%, or roughly NIS 6.8 million. That is helpful because it can support automation and cost improvement. It is also a reminder that Amiad is still in the stage of investing to improve its cost base, not in the stage where the benefits are already fully visible in profitability.

The fifth trigger: 2025 was a management transition year. The CFO left in May, Alex Knor stepped into the roles of deputy CEO, CFO, and COO, and at the start of 2026 Shay Michael became CEO. Leadership changes do not automatically change a thesis, but here they matter because they sit exactly on top of the company’s weak point: management still has to close the gap between a credible efficiency plan and an actual industrial recovery.

There are two more background threads that should stay in view even though the company currently says their impact is not material. The halt in trade between Turkey and Israel remains in force and the company says it still cannot assess the full future effect. On top of that, the U.S. tariff program on imports from Israel and Canada is not expected by the company to be material at present, but it still adds uncertainty to a market that is already dealing with delayed investment in North America.

Efficiency, Profitability And Competition

The most important number in Amiad’s 2025 report is not cash flow. It is the collapse in operating profitability. Revenue fell 8.1% to $120.3 million, but gross profit fell 15.1% to $39.1 million, taking gross margin down to 32.5% from 35.2% in 2024. That means the problem was not just volume. It was also economic quality.

To understand the erosion, the company has to be separated into its two different engines. In irrigation, sales recovered but profitability did not. Segment revenue rose to $56.5 million, while direct operating profit fell to $5.3 million from $6.0 million. Direct margin fell to 9.3% from 11.3%. The company explains why: activity weakened more sharply in higher-margin regions and products, so revenue came back on a weaker mix.

Industry was worse. Segment revenue fell 17.8% to $63.7 million and direct operating profit collapsed 60.5% to just $3.8 million. Direct margin fell to 5.9% from 12.3%. This is not only about mix. The company explicitly points to delayed infrastructure projects, higher production costs in Israel and Turkey, and low profitability in several projects because implementation costs came in above plan. That is the core of the problem. Amiad is not only dealing with a softer end market. It is also absorbing projects that were not closed on attractive enough economics.

The cost breakdown reinforces that conclusion. Cost of revenue fell to $81.1 million from $84.7 million, but that happened alongside lower activity. Materials fell to $46.5 million from $50.4 million, and manufacturing employee benefits fell to $19.7 million from $22.5 million. In other words, the company did take direct cost out, but not nearly enough to offset weaker industrial volume, poorer irrigation mix, and higher production costs.

There is some discipline in indirect expenses. Selling and marketing costs fell by $0.9 million to $27.3 million, which management attributes to better cost structure. On the other hand, G&A rose to $11.9 million from $11.4 million, mainly because of roughly $0.2 million of CEO exit costs, roughly $0.4 million of doubtful debt expense, mainly in Turkey, and the effect of the stronger shekel. That matters because it shows management did cut in the commercial layer, but at the same time had to absorb managerial and credit friction that did not come from demand alone.

Competition looks different in each segment. In irrigation, Amiad benefits from brand, technology breadth, and a global distribution network, but it still depends on OEMs and dealers, which limits pricing power when end markets push toward cheaper alternatives or when sales concentrate in lower-margin regions. In industry, the company competes less as a standard product supplier and more through project integration, engineering fit, and EPC relationships. That market has real technical barriers, but it is also more exposed to project delays and cost overruns. When both hit together, the moat does not disappear, but it stops protecting margin.

One more point that is easy to miss is financing. Net finance expense fell to $1.8 million from $2.8 million, mainly because of finance income from the fair-value remeasurement of derivatives. The company also states that it hedged the dollar against the shekel, and the stronger shekel created finance income in 2025. That is real relief, but it is not operating relief. FX hedging bought Amiad some time. It did not solve the industrial margin and backlog problem.

Cash Flow, Debt And Capital Structure

Cash framing matters a lot here. For Amiad, the relevant lens is all-in cash flexibility, not normalized / maintenance cash generation. The question right now is not how much cash the installed business could theoretically produce before strategic uses. The question is how much cash is left after leases, investment, debt movements, and the real obligations that already happened.

Operating cash flow rose to $5.3 million in 2025 from $3.5 million in 2024. That is true, but it was not driven by better earnings. The company moved from a near-break-even net result to a $4.8 million net loss. What changed is that working-capital drag almost disappeared versus 2024. In 2025, total working-capital movement was only a $0.1 million outflow, compared with a $4.4 million drag in 2024. Receivables and contract assets came down, partially offset by lower operating liabilities. So the cash improvement came less from a stronger business and more from a business that demanded much less working capital, helped in part by industrial weakness.

That is where the easy reading breaks. If the 2025 cash bridge is built on an all-in basis, the company generated $5.3 million from operations, spent $2.6 million on property, plant and equipment, spent $0.4 million on intangible assets, paid $4.0 million on leases, reduced short-term bank debt by roughly $1.0 million, and got small offsets from asset sales and FX. The result was a $2.9 million decline in cash to $8.7 million. Cash flow supported the business, but it did not leave true surplus cash after real uses.

The balance sheet supports the same reading. Cash and equivalents fell to $8.7 million from $11.6 million. Short-term bank debt did edge down to $22.8 million from $23.8 million, but because cash fell faster, net bank debt actually increased to roughly $14.2 million from roughly $12.3 million. Looking only at gross debt reduction misses the fact that liquidity thinned more quickly than borrowings.

On debt structure, there is one clear positive and one clear yellow flag. The positive is that the company has no bank financial covenants, and it still had a $28 million credit facility with $5.2 million unused at year-end, including $1.7 million of committed availability. The yellow flag is that the debt is short term, on call, floating, and priced at SOFR plus 1.68%, while the banks hold a fixed charge over unpaid share capital and goodwill and a floating charge over all assets. There may be no covenant pressure, but there is still real dependence on bank support.

Leases are another layer that should not be ignored. Lease liabilities rose to $18.3 million from $16.3 million, mainly because of renewed agreements in the U.S. and Australia. Anyone looking only at bank debt misses that $4.0 million of annual cash outflow is going into this layer alone. Even if bank borrowings stabilize, the company still has a meaningful fixed cash burden to carry.

There is also a quality issue in operating assets. Inventory rose to $40.1 million and the slow-moving inventory provision increased to $5.8 million from $5.3 million. Net trade receivables fell slightly to $31.8 million, but past-due receivables rose to $19.1 million from $17.3 million, and the expected credit loss allowance rose to $1.0 million from $0.7 million. This is not a credit event, but it does show that the better cash-flow line did not come from an obviously cleaner operating asset base.

Outlook

First finding: 2026 starts from a lower order base, mainly in industry. The company says so directly. When industrial backlog is down 29.3% before the year even starts, this is no longer just a matter of management tone. It is a weaker starting position.

Second finding: irrigation supports the thesis, but it does not carry it alone. The segment benefited from Europe and from Netafim returning to 2023 purchasing levels, and still irrigation direct profitability weakened. So even if irrigation remains stable, it may not be enough to absorb further industrial softness.

Third finding: efficiency is real, but it is not yet a proven thesis. Management keeps pointing to automation, process improvement, production efficiency, and cost actions. That supports the direction. But in 2025 the end result of all that work was still only $5.3 million of adjusted EBITDA, down from $12.4 million. The market is likely to demand numeric proof rather than another planning cycle.

Fourth finding: management is still screening acquisitions and partnerships. That can make strategic sense in adjacent technologies or markets. But as long as the current industrial base has not returned to a comfortable profitability level, M&A is not a cure-all. It can also add execution and financing complexity if pursued too early.

Fifth finding: FX hedging and lower finance expense bought time, but they did not remove the underlying exposure. The company explicitly says the stronger shekel hurt profitability, and that a 1% move in dollar interest rates would change pre-tax profit by $228 thousand. Building the 2026 case mainly on friendlier FX or rates would be too optimistic.

That makes 2026 look like a bridge year that still has to become a proof year. It is not a reset year, because Amiad is not facing a deep cash crisis, it has no financial covenants, and irrigation is showing life again. But it is not a breakout year either, because the industrial engine has not recovered and the improved irrigation mix still does not look cleaner on profitability.

What has to happen for the story to improve? First, industrial backlog has to stop shrinking and return to growth, even modestly. Second, the efficiency actions in Turkey and Israel have to show up in gross margin, not only in indirect costs. Third, irrigation has to stay healthy without becoming even more dependent on Netafim or on lower-quality mix. Fourth, operating cash flow has to remain positive even if working capital stops helping.

Geographic diversification does provide some stability. The U.S., Europe, and Australia together form a large part of revenue, and the company is not dependent on one local market. But diversification is not a perfect shield here. The slowdown in North America already hurt industry, Turkey remains a medium-term uncertainty, and the company still carries meaningful exposure to shekel, euro, and Australian dollar movements. Diversification reduces the chance that one shock becomes an immediate crisis. It does not remove the underlying frictions.

Risks

The first risk is customer concentration in irrigation. Customer A, Netafim, represented 11.6% of group revenue in 2025, and the company explicitly acknowledges dependence on revenue from that customer. When the recovery of an entire segment is tied to one anchor customer returning to former purchase levels, that helps in the short term but also creates a ceiling for the thesis. If that customer normalizes rather than keeps growing, the next leg has to come from somewhere else.

The second risk is industrial backlog quality. The company writes about a meaningful slowdown in North America, delayed infrastructure investment, and weak profitability in certain projects. In that kind of market, it is not enough to count orders. The real question is on what commercial terms they are signed, how much engineering adaptation they require, and how much implementation risk sits inside them. 2025 already delivered an uncomfortable answer.

The third risk is FX and production pressure. The stronger shekel hurt profitability, the company hedges mainly shekel, euro, and Australian dollar exposure, but the derivatives are not designated for hedge accounting. That means part of the relief runs through finance income rather than through cleaner operating results. On top of that, Turkey already pressured the cost base, and the trade halt between Turkey and Israel still sits in the background as an event whose full future effect the company says it cannot yet assess.

The fourth risk is inventory and receivable quality. Inventory remains high, the slow-moving provision rose, past-due receivables increased, and expected credit losses moved higher. Those are not numbers of a company losing control, but they are the numbers of a company entering 2026 without much room for pricing, execution, or collection mistakes.

The fifth risk is short-term financing structure. The absence of covenants matters, and it helps. But the bank debt is still on call, floating, and secured by broad charges over the asset base. If 2026 does not bring an industrial recovery, the question will not be whether the company can meet tomorrow morning’s obligations. It will be how much real strategic freedom it has to keep investing, acquire, or simply wait for the cycle to improve.

Conclusions

Amiad ends 2025 with two opposing stories in the same report. On one side, irrigation recovered, Netafim came back, and operating cash flow turned more supportive. On the other, industry, still the larger revenue segment, lost volume, lost backlog, and lost a large part of its profitability. In the near term the market may initially focus on the better cash-flow line and on softer finance expense, but the deeper question is whether industry is returning to orders and margins, or whether 2025 was mainly a temporary breathing space.

Current thesis: Amiad has real operating assets, geographic reach, and strong product breadth, but right now the business is being held up by a partial irrigation recovery, temporary cash-flow relief, and an efficiency story that has not yet been fully proven in earnings.

What changed versus the older read: 2025 no longer looks like a year of broad-based erosion only. It looks like a sharp split between irrigation stabilizing and industry weakening faster than cost actions can offset.

Counter thesis: It is possible that 2025 was mainly hit by project delays, FX, and Turkey cost inflation, and that once industrial demand returns and efficiency work matures, Amiad can recover to much healthier EBITDA without a structural change in the business mix.

What could change the market’s near-to-medium-term interpretation: a visible industrial backlog recovery in the first half of 2026, gross-margin stabilization without a renewed working-capital drain, and irrigation holding up without becoming even more concentrated around Netafim.

Why this matters: Amiad is no longer being judged only on product quality or global reach. It is being judged on whether it can translate those advantages back into operating profit and real cash left after leases, investment, and financing.

What needs to happen over the next 2 to 4 quarters is straightforward to define and hard to deliver: industrial backlog needs to rebuild, industrial direct profitability needs to recover from 2025 levels, and irrigation has to stay stable without leaning even more on one customer. What would weaken the thesis is another year in which cash flow looks acceptable mainly because working capital stops hurting, while operating profit and backlog still fail to repair.